MPTP-treated mouse models reproduce dopaminergic mitochondrial failure characteristic of PD [33,34], while SOD1^G93A transgenic mice demonstrate mitochondrial swelling, impaired ATP production, and increased ROS generation consistent with ALS pathology [35,36]. This evidence concerns the gene SOD1 and Parkinson disease.